Human apotransferrin (Sanquin Blood Supply Foundation)
N/A
Report date: 2022/11/05 14:07:39
Base Information
Drug NameHuman apotransferrin (Sanquin Blood Supply Foundation)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanquin Plasma Products Bv
China Registration ClassN/A
Develop Information
Active CompaniesSanquin Plasma Products BvProthya Biosolutions Netherlands BV
Inactive CompaniesN/A
Active Indications
Inactive Indications